Phase I Study of Anetumab Ravtansine in Hepatic or Renal Impairment

NCT02696642 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
54
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Bayer